NB
AZN icon

Norinchukin Bank’s AstraZeneca AZN Stock Holding History

Norinchukin Bank’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,751
Closed -$1.79M – 562
2025
Q4 		$1.79M Buy
9,751
+1,507
+18% +$264K 0.02% 329
2025
Q3 		$1.26M Sell
8,244
-503
-6% -$76.1K 0.02% 390
2025
Q2 		$1.22M Buy
8,747
+936
+12% +$131K 0.02% 381
2025
Q1 		$1.15M Buy
7,811
+4,996
+177% +$723K 0.02% 360
2024
Q4 		$369K Buy
2,815
+219
+8% +$30.7K 0.01% 510
2024
Q3 		$404K Buy
2,596
+293
+13% +$47.3K 0.01% 494
2024
Q2 		$359K Sell
2,303
-55
-2% -$8.28K 0.01% 480
2024
Q1 		$320K Sell
2,358
-117
-5% -$15.5K 0.01% 507
2023
Q4 		$333K Sell
2,475
-662
-21% -$86.1K 0.01% 497
2023
Q3 		$425K Sell
3,137
-619
-16% -$84.5K 0.01% 453
2023
Q2 		$538K Sell
3,756
-148
-4% -$21.8K 0.01% 493
2023
Q1 		$542K Sell
3,904
-46
-1% -$6.19K 0.01% 479
2022
Q4 		$536K Sell
3,950
-180
-4% -$22.6K 0.01% 468
2022
Q3 		$453K Buy
4,130
+75
+2% +$9.52K 0.01% 486
2022
Q2 		$536K Buy
4,055
+1,101
+37% +$144K 0.01% 470
2022
Q1 		$392K Buy
+2,954
New +$354K 0.01% 522

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM

Norinchukin Bank's AZN Position: Q1 2026 in Review

Norinchukin Bank sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 9,751 shares — an estimated $1.79M sold.

Norinchukin Bank first reported a position in AZN in Q1 2022 and held it in 16 quarters. The position peaked at $1.79M in Q4 2025. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Norinchukin Bank reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Norinchukin Bank sold 9,751 AstraZeneca shares in Q1 2026, an estimated $1.79M.
  • Norinchukin Bank first reported a position in AstraZeneca in Q1 2022 and held it in 16 quarters.
  • Norinchukin Bank's AstraZeneca position peaked at $1.79M in Q4 2025.
  • 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Norinchukin Bank's 13F filing for Q1 2026, filed 15 May 2026.